680 results on '"Schrumpf, E"'
Search Results
2. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret
3. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis
4. Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells
5. Liver transplantation in patients over 60 years of age
6. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. (Liver Disease)
7. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes
8. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Δ32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients
9. ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
10. Hepatic and extrahepatic malignancies and primary sclerosing cholangitis
11. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries
12. Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients
13. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
14. Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis
15. NEW TIME DEPENDENT PROGNOSTIC MODELS FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
16. TIME DEPENDENT NEURAL NETWORK PROGNOSTIC MODEL FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
17. NATURAL HISTORY OF PRIMARY SCLEROSING CHOLANGITIS. A LONGTERM FOLLOW-UP STUDY OF 394 EUROPEAN PRIMARY SCLEROSING CHOLANGITIS PATIENTS
18. International Autoimmune Hepatitis Group* Report: review of criteria for diagnosis of autoimmune hepatitis
19. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations
20. Pustuløst legemiddelutslett
21. Primary sclerosing cholangitis: Benefits & downsides of EC support 36.10
22. C01/162 Interferon α2b treatment in low activity hepatitis C infection
23. Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.
24. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
25. Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?
26. Primary sclerosing cholangitis: challenges of a new millenium
27. Parenting, Child Culture, and Emotional Relations in Postwar Norway
28. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
29. The Inhibitory Action of Somatostatin on the Stomach
30. Is the 308 polymorphism in the tumor necrosis factor (alpha) (TNF alpha) promoter region a marker of disease susceptibility in European patients with primary sclerosing cholangitis (PSC)?
31. HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups
32. Association of the tumour necrosis factor α -- 308 but not the interleukin 10 -- 627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis
33. Proteomic Analysis of Liver Fibrotic Septa and Periportal Spaces in Primary Sclerosing Cholangitis, Primary Biliary Cholangitis and Alcoholic Liver Disease
34. Lipid Antigens in Bile from Patients with Liver Diseases Activate Natural Killer T Cells
35. Norursodeoxycholic Acid Improves Cholestasis in Primary Sclerosing Cholangitis: Results of a Phase II Dose Finding Study
36. Genotype-Phenotype Analysis across 130,422 Genetic Variants Identifies Rspo3 as the First Genome-Wide Significant Modifier Gene in Primary Sclerosing Cholangitis
37. A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man
38. Liver transplantation in a 23-year-old tyrosinaemia patient: Effects on the renal tubular dysfunction
39. HLA associations in small-duct compared with large-duct primary sclerosing cholangitis
40. P1190 : The role of NKT cells in a mouse model (NOD.C3C4) with spontaneous bile duct inflammation
41. O082 : The gut microbiota in primary sclerosing cholangitis differs from that of healthy controls and ulcerative colitis patients without biliary disease
42. ASSESSMENT OF 479 PATIENTS WITH AUTOIMMUNE LIVER DISEASES ACCORDING TO THE IAIHG SCORING SYSTEM FOR AUTOIMMUNE HEPATITIS DOES NOT SUPPORT THE CONTENTION OF OVERLAP SYNDROMES AS SEPARATE DIAGNOSTIC ENTITIES
43. Prognosis of autoimmune liver diseases
44. Role of polymorphisms in genes involved in bile acid detoxification pathways in primary sclerosing cholangitis
45. Standard treatment for primary sclerosing cholangitis and overlap autoimmune hepatitis/primary sclerosing cholangitis
46. Malignancy in Colonoscopically Removed Polyps1
47. Chemopreventive effect of ursodeoxycholic acid in primary sclerosing cholangitis?
48. P354 CHOLANGIOCYTES FROM PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS EXPRESS CD1D AND HUMAN CHOLANGIOCYTES PRESENT ANTIGENS TO NATURAL KILLER T CELLS
49. O133 NOVEL PROTEIN MARKERS IDENTIFIED IN BILE AND SERUM ARE ASSOCIATED WITH A DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS, DISEASE SEVERITY, AND TRANSPLANT-FREE SURVIVAL
50. P363 ENHANCED LIVER FIBROSIS SCORE PREDICTS TRANSPLANT-FREE SURVIVAL IN PSC INDEPENDENTLY OF THE MAYO RISK SCORE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.